Cargando…
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
Autores principales: | Deeken, John F, Rudek, Michelle A, Moore, Page C, Aboulafia, David, Sullivan, Ryan, Gerecitano, John, Cianfrocca, Mary, Henry, David, Ratner, Lee, Dezube, Bruce, Mosby, Kimberly, Tibbals, Melinda, Little, Richard F, Ivy, S P, Mitsuyasu, Ronald T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330074/ http://dx.doi.org/10.1186/1750-9378-7-S1-O15 |
Ejemplares similares
-
The AIDS malignancy clinical trials consortium (AMC) patient navigator (PN) initiative
por: Botello-Harbaum, Maria T, et al.
Publicado: (2012) -
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
por: Haigentz, Missak, et al.
Publicado: (2022) -
HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration
por: D’Jaen, Gabriela, et al.
Publicado: (2010) -
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075)
por: Ramos, Juan C., et al.
Publicado: (2018) -
PK/PD modeling based on NO-ET homeostasis for improving management of sunitinib-induced hypertension in rats
por: Liu, Hao-chen, et al.
Publicado: (2020)